Members |
acceptabilityId |
Accidental event (event) |
Preferred (foundation metadata concept) |
Accidental exposure to metal and/or metal compound |
Preferred (foundation metadata concept) |
Accidental exposure to metal and/or metal compound (event) |
Preferred (foundation metadata concept) |
Accidental exposure to metallic lead |
Preferred (foundation metadata concept) |
Accidental exposure to metallic lead (event) |
Preferred (foundation metadata concept) |
Accidental fall |
Preferred (foundation metadata concept) |
Accidental fall (event) |
Preferred (foundation metadata concept) |
Accidental injury |
Preferred (foundation metadata concept) |
Accidental injury (disorder) |
Preferred (foundation metadata concept) |
Accidental needle stick injury |
Preferred (foundation metadata concept) |
Accidental needle stick injury (disorder) |
Preferred (foundation metadata concept) |
Accidental physical contact |
Acceptable (foundation metadata concept) |
Accidental physical contact (event) |
Preferred (foundation metadata concept) |
Accidental physical contact or exposure with potential or actual harmful effect |
Preferred (foundation metadata concept) |
Accidental physical contact with animal |
Preferred (foundation metadata concept) |
Accidental physical contact with animal (event) |
Preferred (foundation metadata concept) |
Accidental poisoning by carbon monoxide |
Preferred (foundation metadata concept) |
Accidental poisoning caused by carbon monoxide |
Acceptable (foundation metadata concept) |
Accidental poisoning caused by carbon monoxide (disorder) |
Preferred (foundation metadata concept) |
Accidental pregnancy |
Acceptable (foundation metadata concept) |
Accidental wound |
Preferred (foundation metadata concept) |
Accidental wound (disorder) |
Preferred (foundation metadata concept) |
Accidentally struck by falling object |
Preferred (foundation metadata concept) |
Accidentally struck by falling object (event) |
Preferred (foundation metadata concept) |
Accidentally struck by or against objects or persons |
Preferred (foundation metadata concept) |
Accidentally struck by or against objects or persons (event) |
Preferred (foundation metadata concept) |
Accidents caused by cutting and piercing instruments or objects |
Preferred (foundation metadata concept) |
Accidents caused by cutting and piercing instruments or objects (event) |
Preferred (foundation metadata concept) |
Accidents caused by electric current |
Acceptable (foundation metadata concept) |
Accidents caused by hot substance or object, caustic or corrosive material and steam |
Preferred (foundation metadata concept) |
Accidents caused by hot substance or object, caustic or corrosive material and steam (event) |
Preferred (foundation metadata concept) |
Accidents caused by knives, swords and daggers |
Preferred (foundation metadata concept) |
Accidents caused by knives, swords and daggers (event) |
Preferred (foundation metadata concept) |
Accidents to unpowered road vehicle or conveyance |
Acceptable (foundation metadata concept) |
Accommodation status |
Acceptable (foundation metadata concept) |
Accommodation unsuitable |
Acceptable (foundation metadata concept) |
Accommodative component in esotropia |
Acceptable (foundation metadata concept) |
Accommodative esotropia |
Preferred (foundation metadata concept) |
Accommodative esotropia (disorder) |
Preferred (foundation metadata concept) |
Accretion |
Preferred (foundation metadata concept) |
Accretion (morphologic abnormality) |
Preferred (foundation metadata concept) |
Accumulation of fluid |
Preferred (foundation metadata concept) |
Accumulation of fluid (morphologic abnormality) |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis Ag |
Acceptable (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens only paediatric vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens only paediatric vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B and inactivated whole Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only paediatric vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid and inactivated whole Human Poliovirus serotype 1, 2 and 3 antigens only paediatric vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens only paediatric vaccine |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis antigen |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis only vaccine product |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only paediatric vaccine |
Preferred (foundation metadata concept) |
Acellular Bordetella pertussis, Clostridium tetani toxoid, Corynebacterium diphtheriae toxoid, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens only paediatric vaccine product |
Preferred (foundation metadata concept) |
Acellular blood |
Preferred (foundation metadata concept) |
Acellular blood (serum or plasma) specimen |
Acceptable (foundation metadata concept) |
Acellular blood (serum or plasma) specimen (specimen) |
Preferred (foundation metadata concept) |
Acellular blood (substance) |
Preferred (foundation metadata concept) |
Acellular pertussis vaccine |
Acceptable (foundation metadata concept) |
Acenocoumarol |
Preferred (foundation metadata concept) |
Acenocoumarol (substance) |
Preferred (foundation metadata concept) |
Acenocoumarol 1 mg oral tablet |
Preferred (foundation metadata concept) |
Acenocoumarol only product |
Preferred (foundation metadata concept) |
Acenocoumarol only product in oral dose form |
Preferred (foundation metadata concept) |
Acephalgic migraine |
Acceptable (foundation metadata concept) |
Acetabulum |
Acceptable (foundation metadata concept) |
Acetaminophen |
Acceptable (foundation metadata concept) |
Acetaminophen 100 mg oral tablet |
Acceptable (foundation metadata concept) |
Acetaminophen 100 mg rectal suppository |
Acceptable (foundation metadata concept) |
Acetaminophen 24 mg/mL oral solution |
Acceptable (foundation metadata concept) |
Acetaminophen 24 mg/mL oral suspension |
Acceptable (foundation metadata concept) |
Acetaminophen 25 mg/mL oral suspension |
Acceptable (foundation metadata concept) |
Acetaminophen 250 mg rectal suppository |
Acceptable (foundation metadata concept) |
Acetaminophen 300 mg oral tablet |
Acceptable (foundation metadata concept) |
Acetaminophen 500 mg oral capsule |
Acceptable (foundation metadata concept) |
Acetaminophen 500 mg oral tablet |
Acceptable (foundation metadata concept) |
Acetaminophen and/or dextropropoxyphene poisoning |
Acceptable (foundation metadata concept) |
Acetaminophen only product |
Acceptable (foundation metadata concept) |
Acetaminophen only product in rectal dose form |
Acceptable (foundation metadata concept) |
Acetaminophen overdose (disorder) |
Preferred (foundation metadata concept) |
Acetazolamide |
Preferred (foundation metadata concept) |
Acetazolamide (substance) |
Preferred (foundation metadata concept) |
Acetazolamide 250 mg oral tablet |
Preferred (foundation metadata concept) |
Acetazolamide only product |
Preferred (foundation metadata concept) |
Acetic acid |
Preferred (foundation metadata concept) |
Acetic acid (substance) |
Preferred (foundation metadata concept) |
Acetic acid 20 mg/mL ear solution |
Preferred (foundation metadata concept) |
Acetic acid only product |
Preferred (foundation metadata concept) |
Acetone on breath |
Acceptable (foundation metadata concept) |
Acetyl cysteine |
Acceptable (foundation metadata concept) |
Acetylcysteine |
Preferred (foundation metadata concept) |
Acetylcysteine (substance) |
Preferred (foundation metadata concept) |
Acetylcysteine 100 mg/mL solution for inhalation |
Preferred (foundation metadata concept) |
Acetylcysteine 200 mg/mL solution for injection |
Preferred (foundation metadata concept) |
Acetylcysteine only product |
Preferred (foundation metadata concept) |